Body

ROBO1 helps cells put up stiff resistance

A protein called ROBO1 may delay the progression of breast cancer, according to a paper published in The Journal of Cell Biology. The study, "Loss of miR-203 regulates cell shape and matrix adhesion through ROBO1/Rac/FAK in response to stiffness" by Lily Thao-Nhi Le and colleagues, identifies a signaling pathway that may protect breast cells from the tumorigenic effects of stiff extracellular matrices.

Genetic cause of neurological disease identified

Using the genetic information of two different families with three generations of disease, researchers have identified a new mutation responsible for a degenerative and ultimately fatal movement disorder. Through induced pluripotent stem cell techniques, researchers also grew neurons from one patient in the laboratory to be used in future experiments.

Spongy material helps repair the spine (video)

SAN DIEGO, March 14, 2016 -- Remember those colorful "grow capsules" that blossom into animal-shaped sponges in water? Using a similar idea, scientists have developed biodegradable polymer grafts that, when surgically placed in damaged vertebrae, should grow to be just the right size and shape to fix the spinal column.

Many cancer survivors experience financial burdens

An analysis of US data from 2011 indicates that nearly 29 percent of cancer survivors are financially burdened as a result of their cancer diagnosis and/or treatment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also reveals that such hardships can have lasting physical and mental effects on cancer survivors.

Active surveillance for prostate cancer can give men good quality of life

Choosing ongoing monitoring instead of immediate curative treatment (surgery or radiotherapy) leads to a better overall quality of life for men with low-risk prostate cancer. In fact, the Quality of life (QoL) is about the same as for men who do not have cancer. These are the findings of a new long-term study comparing Active Surveillance, immediate curative treatment, and a reference group of men without cancer, presented at the European Association of Urology Congress in Munich.

DNA 'origami' could help build faster, cheaper computer chips

SAN DIEGO, March 13, 2016 -- Electronics manufacturers constantly hunt for ways to make faster, cheaper computer chips, often by cutting production costs or by shrinking component sizes. Now, researchers report that DNA, the genetic material of life, might help accomplish this goal when it is formed into specific shapes through a process reminiscent of the ancient art of paper folding.

Getting closer to using beer hops to fight disease

SAN DIEGO, March 13, 2016 -- Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.

A step toward a birth control pill for men

SAN DIEGO, March 13, 2016 --Women can choose from a wide selection of birth control methods, including numerous oral contraceptives, but there's never been an analogous pill for men. That's not for lack of trying: For many years, scientists have attempted to formulate a male pill. Finally, a group of researchers has taken a step toward that goal by tweaking some experimental compounds that show promise.

Study finds kidney transplant donation rates vary widely across Europe

A new Europe-wide survey shows significant country-to-country differences in rates of kidney transplant donors. The survey shows for example within the EU, there is a x5 variation in the number of kidney donors per country (per head of population). This variation is probably due to different legal and social standards across Europe.

RNA sequencing opens door to accurate, highly specific test for prostate cancer

A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single test potentially opens the door for simple, accurate non-invasive testing for prostate cancer. This work is presented at the European Association of Urology Congress in Munich.

Almost 1/3 of infertile men at increased risk of metabolic diseases as they age

Munich, 12 March 2016: Men with fertility problems are at increased risk of metabolic diseases as they age, according to work being presented at the European Association of Urology conference in Munich*.

New 'AsthmaMap' could redefine disease and personalize treatment for patients

Estoril, Portugal: A new digital "map" detailing different mechanisms that contribute to the development of asthma could help researchers redefine the disease. The map works by dividing asthma into different subgroups in order to allow personalised treatment more targeted to the type of asthma patients live with.

Details of the AsthmaMap were presented in Estoril, Portugal today (12 March, 2016) at the European Respiratory Society's Lung Science Conference.

Can we predict aggressiveness of prostate cancer before surgery with a blood test?

Prostate cancer is the most common male cancer, with 400,000 new cases every year in Europe. The success of surgery depends on a variety of factors. Now a new study from scientists in Milan has shown that for local prostate cancers treated with radical prostatectomy, you can preoperatively predict the aggressiveness of the prostatic disease, via a simple blood test.

How a bad night's sleep might worsen cancer development

Recent studies have indicated that patients with sleep apnea may be associated with worse cancer outcomes. Now a new animal study, presented at the European Association of Urology Congress in Munich, uncovers a possible mechanism which may underlie this link.

UTSW researchers find newly identified immunity pathway protects mammals from virus-cause

DALLAS - March 10, 2016 - Building upon earlier research, investigators at UT Southwestern Medical Center and their collaborators have identified a new innate immunity pathway that protects mammals from viral oncogenesis, the process by which viruses cause normal cells to become cancerous.

Given the prevalence of virus-related cancers in humans, the discovery is significant - and could eventually contribute to development of new cancer therapies. The findings were published recently in Proceedings of the National Academy of Sciences.